跳至主要内容
临床试验/NCT01412346
NCT01412346已完成不适用

Health Effects of a Nordic Diet Rich in Plant-based Foods and Fish

Finnish Institute for Health and Welfare2 个研究点 分布在 1 个国家目标入组 111 人开始时间: 2011年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
111
试验地点
2
主要终点
Change from baseline in systolic and diastolic blood pressure after treatments

研究概览

简要总结

The purpose of this study is to investigate the effects of a Nordic diet rich in plant-based foods and fish on indicators of cardiovascular disease risk at two different levels of salt intake.

The study is a 20-wk randomized controlled crossover trial. The subjects follow a salt-restricted diet during the study. The study begins with a 4-wk run-in phase for all subjects. After that the subjects are randomly allocated to one of two groups. Group 1 consumes a healthy Nordic low-salt diet enriched with plant-based foods and fish for 16 weeks. Group 2 consumes a low-salt diet for 16 weeks. During the 16 weeks, both groups receive salt and placebo capsules in a double-blind, crossover fashion (8+8 weeks).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • prehypertension or hypertension (systolic blood pressure 130-159 mmHg or diastolic blood pressure 85-99 mmHg)

排除标准

  • regular use of medications
  • intestinal disorders
  • symptomatic cardiovascular disease
  • obesity (BMI>35 kg/m2)
  • vegetarianism
  • high intake of alcohol
  • allergy to fish
  • pregnancy

结局指标

主要结局

Change from baseline in systolic and diastolic blood pressure after treatments

时间窗: 12 and 20 weeks

次要结局

  • Change from baseline in PFA-100 measurements after treatments(12 and 20 weeks)
  • Change from baseline in biomarkers of cardiovascular disease risk after treatments(12 and 20 weeks)
  • Change from baseline in nutritional biomarkers after treatments(12 and 20 weeks)
  • Change from baseline in blood cell gene expression after treatments(12 and 20 weeks)

研究者

发起方
Finnish Institute for Health and Welfare
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Iris Erlund

PhD., senior researcher

Finnish Institute for Health and Welfare

研究点 (2)

Loading locations...

相似试验